Tauriga Sciences, Inc. Sample Contracts

Tauriga Sciences, Inc. – Contract (October 8th, 2019)

THIS NOTE AND THE COMMON STOCK ISSUABLE UPON CONVERSION OF THIS NOTE HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND THE RULES AND REGULATIONS PROMULGATED THEREUNDER (THE “1933 ACT”)

Tauriga Sciences, Inc. – SECURITIES PURCHASE AGREEMENT (October 8th, 2019)

This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of September 13, 2019 by and between Tauriga Sciences, Inc., a Florida corporation, with headquarters located at 555 Madison Avenue, 5th Floor, New York, NY 10022 (the “Company”), and ODYSSEY FUNDING, LLC, a Delaware limited liability company, with its address at 1249 Broadway, Suite 103, Hewlett, NY 11557 (the “Buyer”).

Tauriga Sciences, Inc. – CONVERTIBLE PROMISSORY NOTE (August 13th, 2019)

This Note is free from all taxes, liens, claims and encumbrances with respect to the issue thereof and shall not be subject to preemptive rights or other similar rights of shareholders of the Borrower and will not impose personal liability upon the holder thereof.

Tauriga Sciences, Inc. – SECURITIES PURCHASE AGREEMENT (August 13th, 2019)

This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of July 22, 2019, by and between TAURIGA SCIENCES INC., a Florida corporation, with its address at 555 Madison Avenue, 5th Floor, New York, New York 10022 (the “Company”), and JEFFERSON STREET CAPITAL LLC, a New Jersey limited liability company, with its address at 900 Monroe Street, Suite 908, Hoboken, New Jersey 07030 (the “Buyer”).

Tauriga Sciences, Inc. – Distribution Agreement Entered into Between Tauriga Sciences Inc.& Sai Krishna LLC} Livingston, NJ 07039 SS # XXX-XX-4076 May 11, 2019 (August 13th, 2019)

This (this “Agreement”), dated as of May 11, 2019 (the “Effective Date”), by and between Tauriga Sciences Inc. (“TAUG”), located in New York, NY 10022 (the “Company”), and Ms. Neelima Lekkala (“Ms. Lekkala”) located in Livingston, NJ 07039 is a sub-agreement — Pursuant to Section IV, Item # 1 (page #4), of the effective April 30, 2019 effective date Distribution Agreement — referenced above - entered into between Tauriga Sciences Inc. and Sai Krishna LLC.

Tauriga Sciences, Inc. – DISTRIBUTION AGREEMENT (July 5th, 2019)

THIS DISTRIBUTION AGREEMENT (the “Agreement”) is made effective as of the Effective Date between the Company and the Client, the definition of each of which are set forth on the annexed schedule.

Tauriga Sciences, Inc. – Contract (June 27th, 2019)

THIS NOTE AND THE COMMON STOCK ISSUABLE UPON CONVERSION OF THIS NOTE HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND THE RULES AND REGULATIONS PROMULGATED THEREUNDER (THE “1933 ACT”)

Tauriga Sciences, Inc. – Contract (June 27th, 2019)

THIS NOTE AND THE COMMON STOCK ISSUABLE UPON CONVERSION OF THIS NOTE HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND THE RULES AND REGULATIONS PROMULGATED THEREUNDER (THE “1933 ACT”)

Tauriga Sciences, Inc. – Contract (June 27th, 2019)

THIS NOTE AND THE COMMON STOCK ISSUABLE UPON CONVERSION OF THIS NOTE HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND THE RULES AND REGULATIONS PROMULGATED THEREUNDER (THE “1933 ACT”)

Tauriga Sciences, Inc. – SECURITIES PURCHASE AGREEMENT (June 27th, 2019)

This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of May 23, 2019, by and between Tauriga Sciences, Inc., a Florida corporation, with headquarters located at 39 Old Ridgebury Road, Danbury, CT 06180 (the “Company”), and GS CAPITAL PARTNERS, LLC, with its address at 30 Broad Street, Suite 1201, New York, NY 10004 (the “Buyer”).

Tauriga Sciences, Inc. – SECURITIES PURCHASE AGREEMENT (June 27th, 2019)

This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of June 21, 2019, by and between Tauriga Sciences, Inc., a Florida corporation, with headquarters located at 555 Madison Ave, 5th Floor, New York, NY 10022 (the “Company”), and GS CAPITAL PARTNERS, LLC, with its address at 30 Broad Street, Suite 1201, New York, NY 10004 (the “Buyer”).

Tauriga Sciences, Inc. – SECURITIES PURCHASE AGREEMENT (June 27th, 2019)

This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of March 14, 2019, by and between Tauriga Sciences, Inc., a Florida corporation, with headquarters located at 39 Old Ridgebury Road, Danbury, CT 06180 (the “Company”), and GS CAPITAL PARTNERS, LLC, with its address at 30 Broad Street, Suite 1201, New York, NY 10004 (the “Buyer”).

Tauriga Sciences, Inc. – NON-EXCLUSIVE DISTRIBUTION AGREEMENT FOR REGION OF NEW JERSEY (NORTHEAST USA) DURATION: 12-Month (“1 Year”) Agreement (May 3rd, 2019)

This Amended and Restated Comprehensive Distribution Agreement (this “Agreement”) is made effective as of April 30, 2019 by and between Tauriga Sciences Inc (OTCQB: TAUG) (“TAUG” or “Tauriga”), a Florida corporation, with a principal address of 555 Madison Avenue, 5th Floor New York, NY 10022 and Sai Krishna LLC (“SKL”), a New Jersey corporation (engaged in distribution, marketing, and fulfillment of products —mainly to the spirits industry and convenient stores), with its mailing address at 27 Wingate Drive // Livingston, NJ 07039.

Tauriga Sciences, Inc. – COMPREHENSIVE DISTRIBUTION AGREEMENT (April 15th, 2019)

Re: Distribution of Tauriga’s CBD Infused Chewing Gum Product Line (Branded as Tauri-Gum™) focusing on the New York City Metropolitan Area Retail Marketplace.

Tauriga Sciences, Inc. – SECURITIES PURCHASE AGREEMENT Tauriga Sciences Inc. (OTCQB: TAUG) New York, NY 10022 Attn: Seth M. Shaw, Chief Executive Officer. DATE: March ____, 2019 (April 15th, 2019)

THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of March _____, 2019, by and among Tauriga Sciences, Inc., a Florida corporation (the “Company”), and the Subscriber identified on the signature pages hereto (the “Subscriber”).

Tauriga Sciences, Inc. – NON-EXCLUSIVE DISTRIBUTION AGREEMENT FOR REGION OF SOUTH FLORIDA (April 15th, 2019)

This Amended and Restated Comprehensive Distribution Agreement (this “Agreement”) is made effective as of April 8, 2019 by and between Tauriga Sciences Inc. (OTCQB: TAUG) (“TAUG” or “Tauriga”), a Florida corporation, with a principal address of 555 Madison Avenue, 5th Floor New York, NY 10022 and IRM Management Corporation (“IRM”), a Florida Corporation, with its mailing address at 1818 South Australian Ave, Ste. 104 // West Palm Beach, FL, 33409.

Tauriga Sciences, Inc. – Contract (April 15th, 2019)

THIS NOTE AND THE COMMON STOCK ISSUABLE UPON CONVERSION OF THIS NOTE HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND THE RULES AND REGULATIONS PROMULGATED THEREUNDER (THE “1933 ACT”)

Tauriga Sciences, Inc. – SECURITIES PURCHASE AGREEMENT (April 15th, 2019)

This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of March 14, 2019, by and between Tauriga Sciences, Inc., a Florida corporation, with headquarters located at 39 Old Ridgebury Road, Danbury, CT 06180 (the “Company”), and GS CAPITAL PARTNERS, LLC, with its address at 30 Broad Street, Suite 1201, New York, NY 10004 (the “Buyer”).

Tauriga Sciences, Inc. – Contract (January 29th, 2019)

THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR UNDER THE SECURITIES LAWS OF CERTAIN STATES. THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE ACT AND THE APPLICABLE STATE SECURITIES LAWS, PURSUANT TO REGISTRATION OR EXEMPTION THEREFROM. LENDERS SHOULD BE AWARE THAT THEY MAY BE REQUIRED TO BEAR THE FINANCIAL RISKS OF THIS INVESTMENT FOR AN INDEFINITE PERIOD OF TIME. THE ISSUER OF THESE SECURITIES MAY REQUIRE AN OPINION OF COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE ISSUER TO THE EFFECT THAT ANY PROPOSED TRANSFER OR RESALE IS IN COMPLIANCE WITH THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS.

Tauriga Sciences, Inc. – Contract (January 29th, 2019)

THIS NOTE AND THE COMMON STOCK ISSUABLE UPON CONVERSION OF THIS NOTE HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND THE RULES AND REGULATIONS PROMULGATED THEREUNDER (THE “1933 ACT”)

Tauriga Sciences, Inc. – SECURITIES PURCHASE AGREEMENT (January 29th, 2019)

This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of January 15, 2019, by and between TAURIGA SCIENCES, INC., a Florida corporation, with headquarters located at 555 Madison Avenue, 5th Floor, New York, NY 10022, (the “Company”), and EAGLE EQUITIES, LLC, a Nevada limited liability company, with its address at 91 Shelton Ave, Suite 107, New Haven, CT 06511 (the “Buyer”).

Tauriga Sciences, Inc. – SECURITIES PURCHASE AGREEMENT (January 29th, 2019)

This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of December 20, 2018, by and between TAURIGA SCIENCES, INC., a Florida corporation, with headquarters located at 555 Madison Avenue, 5th Floor, New York, NY 10022, (the “Company”), and Adar Alef, LLC, a New York limited liability company, with its address at 38 Olympia Ln, Monsey, NY 10952 (the “Buyer”).

Tauriga Sciences, Inc. – SECURITIES PURCHASE AGREEMENT Tauriga Sciences Inc. (OTCQB: TAUG) New York, NY 10022 Attn: Seth M. Shaw, Chief Executive Officer. DATE: January 8, 2019 (January 29th, 2019)

THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of January 8, 2019, by and among Tauriga Sciences, Inc., a Florida corporation (the “Company”), and the Subscriber identified on the signature pages hereto (the “Subscriber”).

Tauriga Sciences, Inc. – Contract (January 29th, 2019)

THIS NOTE AND THE COMMON STOCK ISSUABLE UPON CONVERSION OF THIS NOTE HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND THE RULES AND REGULATIONS PROMULGATED THEREUNDER (THE “1933 ACT”)

Tauriga Sciences, Inc. – Contract (January 29th, 2019)

THIS NOTE AND THE COMMON STOCK ISSUABLE UPON CONVERSION OF THIS NOTE HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND THE RULES AND REGULATIONS PROMULGATED THEREUNDER (THE “1933 ACT”)

Tauriga Sciences, Inc. – PER OS BIOSCIENCES CONTRACT MANUFACTURING AGREEMENT FOR CHEWING GUM Terms and Conditions (January 29th, 2019)
Tauriga Sciences, Inc. – New York, NY 10022 Attn: Seth M. Shaw, Chief Executive Officer AGREEMENT FOR CONSULTANT TO THE COMPANY With (January 29th, 2019)

This (this “Agreement”), dated as of January 11, 2019 (the “Effective Date”), by and between Tauriga Sciences Inc., located in New York, NY 10022 (the “Company”), and J. Safier Enterprises LLC, a sole proprietorship operated by Mr. Jamie Safier (“Mr. Safier”) with an address at 6 The Hemlocks / Roslyn, NY 11576 (the “Consultant”).

Tauriga Sciences, Inc. – Contract (October 31st, 2018)

THIS NOTE AND THE COMMON STOCK ISSUABLE UPON CONVERSION OF THIS NOTE HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND THE RULES AND REGULATIONS PROMULGATED THEREUNDER (THE “1933 ACT”)

Tauriga Sciences, Inc. – SECURITIES PURCHASE AGREEMENT (October 31st, 2018)

This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of October 25, 2018, by and between Tauriga Sciences, Inc., a Florida corporation, with headquarters located at 39 Old Ridgebury Road, Danbury, CT 06180 (the “Company”), and GS CAPITAL PARTNERS, LLC, with its address at 30 Broad Street, Suite 1201, New York, NY 10004 (the “Buyer”).

Tauriga Sciences, Inc. – SETTLEMENT AND RELEASE OF TAURIGA SCIENCES, INC Between Tauriga Sciences Inc. & Solomon Sharbat (and all related entities) OCTOBER 23, 2018 (October 31st, 2018)

This Settlement and Release (the “Agreement”) is made this 23rd day of October, 2018 by and between Seth Shaw and Tauriga Sciences, Inc., a Florida corporation (“also herein referenced as: “TAURIGA” TAUG” or the”Company”), having its principal place of business located at 555 Madison Avenue, 5th Floor, New York, NY 10022 (collectively hereinafter referred to as “Payer”) and Solomon Sharbat & all Related Sharbat Parties (Collectively herein referred to as “Payee”) an individual residing at Gush Halav 10, Tel Aviv, Israel and his entities (also collectively hereinafter referred to as “Claimant”).

Tauriga Sciences, Inc. – SECURITIES PURCHASE AGREEMENT (July 31st, 2018)

This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of May 10, 2018, by and between Tauriga Sciences, Inc., a Florida corporation, with headquarters located at 39 Old Ridgebury Road, Danbury, CT 06180 (the “Company”), and GS CAPITAL PARTNERS, LLC, with its address at 110 Wall Street, Suite 5-070, New York, NY 10005 (the “Buyer”).

Tauriga Sciences, Inc. – Contract (July 31st, 2018)

THIS NOTE AND THE COMMON STOCK ISSUABLE UPON CONVERSION OF THIS NOTE HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND THE RULES AND REGULATIONS PROMULGATED THEREUNDER (THE “1933 ACT”)

Tauriga Sciences, Inc. – Contract (June 27th, 2018)

THIS NOTE AND THE COMMON STOCK ISSUABLE UPON CONVERSION OF THIS NOTE HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND THE RULES AND REGULATIONS PROMULGATED THEREUNDER (THE “1933 ACT”)

Tauriga Sciences, Inc. – Contract (June 27th, 2018)

NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON CONVERSION OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

Tauriga Sciences, Inc. – Contract (June 27th, 2018)

THIS NOTE AND THE COMMON STOCK ISSUABLE UPON CONVERSION OF THIS NOTE HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND THE RULES AND REGULATIONS PROMULGATED THEREUNDER (THE “1933 ACT”)